<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">18160</article-id><article-id pub-id-type="doi">10.15690/vramn18160</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ONCOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ОНКОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Personalised radiation therapy of cervical cancer</article-title><trans-title-group xml:lang="ru"><trans-title>Персонифицированная радиотерапия рака шейки матки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2630-4961</contrib-id><contrib-id contrib-id-type="spin">3331-9121</contrib-id><name-alternatives><name xml:lang="en"><surname>Salim (Islim)</surname><given-names>Nidal</given-names></name><name xml:lang="ru"><surname>Салим (Ислим)</surname><given-names>Нидаль</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>salnidal@yahoo.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-4961-4810</contrib-id><contrib-id contrib-id-type="spin">6795-9072</contrib-id><name-alternatives><name xml:lang="en"><surname>Stolbovoy</surname><given-names>Alexander V.</given-names></name><name xml:lang="ru"><surname>Столбовой</surname><given-names>Александр Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Assistant Professor</p></bio><bio xml:lang="ru"><p>д.м.н., доцент</p></bio><email>lefortovo@hotmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6909-8558</contrib-id><contrib-id contrib-id-type="spin">1975-4356</contrib-id><name-alternatives><name xml:lang="en"><surname>Loyko</surname><given-names>Ilya E.</given-names></name><name xml:lang="ru"><surname>Лойко</surname><given-names>Илья Евгеньевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>iloyko@emsmos.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-8357-8011</contrib-id><contrib-id contrib-id-type="spin">1165-8800</contrib-id><name-alternatives><name xml:lang="en"><surname>Zvereva</surname><given-names>Darya P.</given-names></name><name xml:lang="ru"><surname>Зверева</surname><given-names>Дарья Павловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dzvereva@emcmcos.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0008-9469</contrib-id><contrib-id contrib-id-type="spin">9802-0579</contrib-id><name-alternatives><name xml:lang="en"><surname>Tumanova</surname><given-names>Kristina O.</given-names></name><name xml:lang="ru"><surname>Туманова</surname><given-names>Кристина Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ktumanova@emcmos.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">European Medical Center</institution></aff><aff><institution xml:lang="ru">Европейский медицинский центр</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного профессионального образования</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-06-19" publication-format="electronic"><day>19</day><month>06</month><year>2026</year></pub-date><volume>81</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>116</fpage><lpage>126</lpage><history><date date-type="received" iso-8601-date="2025-12-09"><day>09</day><month>12</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2026-03-26"><day>26</day><month>03</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Издательство "Педиатръ"</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-12-19"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/18160">https://vestnikramn.spr-journal.ru/jour/article/view/18160</self-uri><abstract xml:lang="en"><p>The article deals certain necessity and contemporary possibility of method of radiotherapy (RT) component in the treatment of cervical cancer (CC) which is alternative to traditional recommendations. RT of CC accordingly to main manuals begins from external beam irradiation (EBRT) and next intracavitary/interstitial brachytherapy (BT). We see this program stand stock-still during a century, despite it not rarely possible to realize oncologic problems in the care of patients. The article contains historic analysis and arguments, that advanced contemporary EBRT may be successful alternative treatment in definite part of the patients. Traditional approach doesn’t disclaim, but here are consider the situations in the article, where new personalized care is more justify. The information was searched using our key words in the bases Rosoncoweb and PubMed, in which articles selected as possible as no more five-years old, but the earliest classic publications also used. There was done retrospective search of the information according our topic from our days to the origin of treatment method of CC in the articles else. We studied Russian and international documents about methods of RT in CC. Before to send the article in the journal we searched publications according to our theme in leading Russian and foreign radiotherapy and oncology journals.</p></abstract><trans-abstract xml:lang="ru"><p>В статье в историческом аспекте рассматривается необходимость и доказывается современная возможность методики радиотерапии больных раком шейки матки (РМШ), альтернативной классическим рекомендациям. Показано, что застывшее на протяжении десятилетий утверждение о сочетанном облучении (сначала дистанционное, затем брахитерапия) на практике не всегда способно соответствовать онкологическим задачам в ведении пациенток. В статье содержится анализ и доказательства того, что современная передовая дистанционная лучевая терапия может быть успешной альтернативой традиционному лечению у определенной части больных. Традиционный подход не отрицается, но рассматриваются ситуации, в которых новое персонифицированное лечение более оправдано. Поиск информации проводился по перечисленным ниже ключевым словам в информационных базах Rosoncoweb и PubMed, в которых отбирались материалы по возможности не более пятилетней давности, но ранние классические работы тоже использованы. Сделан также ретроспективный поиск информации по теме от наших дней до истоков радиотерапии РШМ, изучены отечественные и международные методические документы по теме, перед подачей статьи в редакцию изучены публикации по теме за последние два года в ведущих отечественных и зарубежных журналах по радиотерапии и онкогинекологии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Cervical cancer</kwd><kwd>radiotherapy</kwd><kwd>brachytherapy</kwd><kwd>guidelines</kwd><kwd>standards</kwd><kwd>adaptive irradiation</kwd><kwd>Image-guided adaptive external beam radiation therapy (IGAEBRT)</kwd><kwd>personalized treatment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак шейки матки</kwd><kwd>радиотерапия</kwd><kwd>брахитерапия</kwd><kwd>рекомендации</kwd><kwd>стандарты</kwd><kwd>адаптивное облучение</kwd><kwd>Image guided adaptive external beam radiation therapy (IGAEBRT)</kwd><kwd>персонифицированное лечение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Рак шейки матки. Клинические рекомендации. Минздрав России. ID: 537_3 // Рубрикатор клинических рекомендаций. М., 2025. Available from: https://cr.minzdrav.gov.ru/preview-cr/537_3 (accessed: 21.04.2025).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>National Comprehensive Cancer Network (NCCN) Guidelines v.4.2025 NCCN Guidelines Version 4.2025 Cervical Cancer // NCCN Guidelines Version 4.2025 Cervical Cancer. Available from: www.nccn.org/professionals/physician_gls/pdf/cervical.pdf (accessed: 21.04.2025).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Cibula D., Pötter R., Planchamp F., et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Virchows Arch. 2018;472(6):919–936. doi: https://doi.org/10.1007/s00428-018-2362-9</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Бойко А.В., Демидова Л.В., Дунаева Е.А., и др. Рак шейки матки // Стандарты лучевой терапии / под ред. А.Д. Каприна, А.А. Костина, Е.В. Хмелевского. — М.: ГЭОТАР-Медиа, 2019. — С. 221–227. [Bojko AV, Demidova LV, Dunaeva EA, i dr. Rak shejki matki // Standarty luchevoj terapii / pod red. A.D. Kaprina, A.A. Kostina, E.V. Hmelevskogo. Moscow: GEOTAR-Media; 2019. S. 221–227. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Viswanathan A, Kiristis C, Erickson B, et al. (eds) Gynecologic radiation therapy: Novel approaches to image-guidance and managment. Springer, Heidellberg; 2011. Р. 119–130.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Viswanathan A, Kirisits C, Beth E, et al. (еds) Gynecologic Radiation Therapy. Novel Approaches to Image-Guidance and Management. Springer-Verlag Berlin Heidelberg; 2011. 308 p.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Viswanathan A. Uterine cervix // Halperin E, Wazer D, Perez C, et al. (eds) Perez and Brady’s principles and practice of radiation oncology. 7th ed. Philadelphia: Wolters Kluwer; 2018. P. 1651–1739.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Damast S, Fields E, Kidd E, et al. Reports From Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2021;111(2):299–306. doi: https://doi.org/10.1016/j.ijrobp.2021.05.002</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Olawaiye AB, Baker TP, Washington MK, et al. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J Clin. 2021;71(4):287–298. doi: https://doi.org/10.3322/caac.21663</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):28–44. doi: https://doi.org/10.1002/ijgo.13865</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Benedetti-Panici P, Greggi S, Colombo А, et al. Neoadjuvant Chemotherapy and Radical Surgery Versus Exclusive Radiotherapy in Locally Advanced Squamous Cell Cervical Cancer: Results From the Italian Multicenter Randomized Study. J Clin Oncol. 2002;20(1):179–188. doi: https://doi.org/10.1200/jco.2002.20.1.179</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Jemal A, Ward EM, Johnson CJ, et al. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Natl Cancer Inst. 2017;109(9):djx030. doi: https://doi.org/10.1093/jnci/djx030</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Состояние онкологической помощи населению России в 2022 году / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. — М.: МНИОИ им. А.П. Герцена, 2023. — С. 31. [Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2022 godu / pod red. AD Kaprina, VV Starinskogo, AO Shahzadovoj. Moscow: MNIOI im. A.P. Gercena; 2023. S. 31. (In Russ.)]</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Landoni F, Maneo A, Colombo A, et al. Randomised stady of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet. 1997;350(9077):535–540. doi: https://doi.org/10.1016/S0140-6736(97)02250-2</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Cengiz M, Gurdalli S, Genc M, et al. Comment on “Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and histopathologic finding in 33 patients with operable cervix carcinoma”. Radiother Oncol. 2005;75(3):367–368. doi: https://doi.org/10.1016/j.radonc.2005.03.018</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Cengiz M, Gurdalli S, Selek U, et al. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: tree-dimentional computed tomography plan evaluation. Int J Rad Oncol Boil Phys. 2008;70(2):464–468. doi: https://doi.org/10.1016/j.ijrobp.2007.06.048</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Acta Unio Internationalis contra Cancrum. 1939. Vol. IV. No. 1-2. Numero consacre a la Semaine Internationale contre le Cancer et a le Reunion Internationale pour la Commemoration de la Decouverte de Radium, des Electrons, des Rayons-X et des Ondes Hertziennes, Hermann &amp; Cie, Paris.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kottmeier HL. Modern trends in the treatment of cancer of the cervix. Acta Radiol Suppl. 1954;116:405–414. doi: https://doi.org/10.3109/00016925409177214</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Baclesse F. Roentgen therapy alone in the treatment of advanced cervico-uterine cancer, including extensive post-operative recurrences. Am J Roentgenol Radium Ther. 1950;63(2):252–254.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Barraclough L, Swindell R, Livsey J. EExternal beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int J Radiation Oncology Biol Phys. 2008;71(3):772–778. doi: https://doi.org/10.1016/j.ijrobp.2007.10.066</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer. 1983;51(5):959–967. doi: https://doi.org/10.1002/1097-0142(19830301)51:5&lt; 959::aid-cncr2820510533&gt;3.0.co;2-k</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ulmer HU, Frischbier HJ. Treatment of advanced cancers of the cervix uteri with external irradiation alone. Int J Radiat Oncol Biol Phys. 1983;9(6):809–812. doi: https://doi.org/10.1016/0360-3016(83)90005-6</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kottmeier HL. The classification and clinical staging of carcinoma of the uterus and vagina: a report by the cancer committee of the international federation of gynaecology and obstetrics. Journal of the International Federation of Gynaecology and Obstetrics. 1963;1(2):83–93. doi: https://doi.org/10.1002/j.1879-3479.1963.tb00327.x</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Ferreira P, Braga-Filho A, Barletta A, et al. Radiation therapy alone in stage III-B cancer of the uterine cervix — a 17-year old experience in southern Brazil. Int J Radiat Oncol Biol Phys. 1999;45(2):441–446. doi: https://doi.org/10.1016/s0360-3016(99)00178-9</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yahya S, Bhatt L, King M, et al. Survival and Toxicity Following Chemoradiation for Carcinoma of the Cervix — Impact of Multiple-phase Treatment and Shielding. Anticancer Res. 2015;35(10):5567–5574.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Akine Y, Hashida I, Kajiura Y, et al. Carcinoma of the uterine cervix treated with external irradiation alone. Int J Radiat Oncol Biol Phys. 1986;12(9):1611–1616. doi: https://doi.org/10.1016/0360-3016(86)90286-5</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Yamamoto R, Yonesaka A, Nishioka S, et al. High dose three-dimensional conformal boost (3DCB) using an orthogonal diagnostic X-ray set-up for patients with gynecological malignancy: a new application of real-time tumor-tracking system. Radiother Oncol. 2004;73(2):219–222. doi: https://doi.org/10.1016/j.radonc.2004.08.006</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Saibishkumar E, Patel F, Sharma S, et al. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis. Clin Oncol (R Coll Radiol). 2006;18(1):46–51. doi: https://doi.org/10.1016/j.clon.2005.10.004</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Wahab S, Malyapa R, Mutic S, et al. A treatment planning study comparing HDR and AGIMRT for cervical cancer. Med Phys. 2004;31(4):734–743. doi: https://doi.org/10.1118/1.1645678</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Pedicini P, Strigari L, Caivano R, et al. Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer. J Appl Clin Med Phys. 2013;14(2):4075. doi: https://doi.org/10.1120/jacmp.v14i2.4075</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Quinn M, Benedet J, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103. doi: https://doi.org/10.1016/S0020-7292(06)60030-1</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Максимов С.Я., Гусейнов К.Д. Комбинированное лечение рака шейки матки // Практическая онкология. — 2002. — Т. 3. — № 3. — С. 200–210. [Maksimov SYa, Gusejnov KD. Kombinirovannoe lechenie raka shejki matki. Prakticheskaya Onkologiya. 2002;3(3):200–210. (In Russ.)]</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Coia L, Won M, Lanciano R, et al. The patterns of care outcome study for cancer of uterine cervix/ Results of second national practice survey. Cancer. 1990;66(12):2451–2456. doi: https://doi.org/10.1002/1097-0142(19901215)66:12&lt; 2451::aid-cncr2820661202&gt;3.0.co;2-5</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Bandyopadhyay A, Mukherjee U, Ghosh S, et al. Pattern of Failure with Locally Advanced Cervical Cancer — A Retrospective Audit and Analysis of Contributory Factors. Asian Pac J Cancer Prev. 2018;19(1):73–79. doi: https://doi.org/10.22034/APJCP.2018.19.1.73</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Kagei K, Tokuuye K, Okumura T, et al. Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 2003;55(5):1265–1271. doi: https://doi.org/10.1016/s0360-3016(02)04075-0</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Matsuura K, Tanimoto H, Fujita K, et al. Early clinical outcomes of 3D-conformal radiotherapy using accelerated hyperfractionation without intracavitary brachytherapy for cervical cancer. Gynecol Oncol. 2007;104(1):11–14. doi: https://doi.org/10.1016/j.ygyno.2006.06.033</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kilic S, Cracchiolo B, Mahmoud O. Non-brachytherapy alternatives in cervical cancer radiotherapy: Why not? Applied radiation oncology. 2015. December. P. 10–17. doi: https://doi.org/10.37549/ARO1081</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Cengiz M, Dogan A, Ozyigit G, et al. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy. 2012;11(2):125–129. doi: https://doi.org/10.1016/j.brachy.2011.12.001</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Nombela-Arrieta C, Manz MG. Quantification and three-dimensional microanatomical organization of the bone marrow. Blood Adv. 2017;1(6):407–416. doi: https://doi.org/10.1182/bloodadvances.2016003194</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48–60. doi: https://doi.org/10.1016/j.ctro.2018.01.001</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Assenholt M, Petersen J, Nielsen S, et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol. 2008;47(7):1337–1343. doi: https://doi.org/10.1080/02841860802266698</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Fetcher G. Textbook of radiotherapy. Philadelphia: Lea &amp; Febiger, 1966. P. 434–474.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Dimopoulos JC, Kirisits C, Petric P, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys. 2006;66(1):83–90. doi: https://doi.org/10.1016/j.ijrobp.2006.04.041</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Kirisits C, Lang S, Dimopoulos J, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65(2):624–630. doi: https://doi.org/10.1016/j.ijrobp.2006.01.036</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Крейнина Ю.М. Брахитерапия в лечении онкогинекологической патологии на современном этапе: state-of-art // Материалы VII Петербургского международного онкологического форума «Белые ночи» 21–27 июня 2021 г. — СПб., 2021. — 382 с. [Krejnina YuM. Brahiterapiya v lechenii onkoginekologicheskoj patologii na sovremennom etape: state-of-art. Materialy VII Peterburgskogo mezhdunarodnogo onkologicheskogo foruma “Belye nochi” 21–27 iyunya 2021 g. Saint Petersburg; 2021. 382 s. (In Russ.)]</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Assenholt M, Vestergaard A, Kallehauge J, et al. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Brachytherapy. 2014;13(4):361–368. doi: https://doi.org/10.1016/j.brachy.2014.02.003</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Aydogan B, Mundt A, Smith B, et al. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2006;65(1):266–273. doi: https://doi.org/10.1016/j.ijrobp.2005.12.049</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Cilla S, Macchia G, Mattiucci G, et al. Optimized stereotactic volumetric modulated arc therapy as an alternative to brachytherapy for vaginal cuff boost. A dosimetric study. Med Dosim. 2020;45(4):352–358. doi: https://doi.org/10.1016/j.meddos.2020.05.003</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Prescribing, recording, and reporting brachytherapy for cancer of the cervix. J ICRU. 2013;13(1–2):NP. doi: https://doi.org/10.1093/jicru/ndw027</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Buschmann M, Majercakova K, Sturdza A, et al. Image guided adaptive external beam radiation therapy for cervix cancer: Evaluation of a clinically implemented plan-of-the-day technique. Z Med Phys. 2018;28(3):184–195. doi: https://doi.org/10.1016/j.zemedi.2017.09.004</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>van de Schoot AJAJ, de Boer P, Visser J, et al. Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy. Acta Oncol. 2017;56(5):667–674. doi: https://doi.org/10.1080/0284186X.2017.1287949</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Georg D, Kirisits C, Hillbrand M, et al. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008;71(4):1272–1278. doi: https://doi.org/10.1016/j.ijrobp.2008.03.032</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Mayr N, Huang Z, Sohn J, et al. Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Rev Anticancer Ther. 2011;11(7):1069–1075. doi: https://doi.org/10.1586/era.11.81</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Mollà M, Escude L, Nouet P, et al. Fractionated radiotherapy boost for gynecologic tumors: an alternative to brachytherapy? Int J Radiat Oncol Biol Phys. 2005;62(1):118–124. doi: https://doi.org/10.1016/j.ijrobp.2004.09.028</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Choi C, Chul C, Yoo S, et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys. 2009;74(1):147–153. doi: https://doi.org/10.1016/j.ijrobp.2008.07.020</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Teh B, Ishiyama H, Mathews T, et al. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. Discov Med. 2010;10(52):255–262.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Jorcano S, Molla M, Escude L, et al. Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapy. Technol Cancer Res Treat. 2010;9(5):509–514. doi: https://doi.org/10.1177/153303461000900509</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Hsieh CH, Weil MC, Hsu YP, et al. Should helical tomotherapy replace brachytherapy for cervical cancer? Case report. BMC Cancer. 2010;10:637. doi: https://doi.org/10.1186/1471-2407-10-637</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Marnitz S, Köhler C, Budach V, et al. Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma. Radiat Oncol. 2013;8:109. doi: https://doi.org/10.1186/1748-717X-8-109</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Столбовой А.В., Ислим Н., Лойко И.Е., и др. Проблемы в лечении рака шейки матки // Клинический разбор в общей медицине. — 2024. — Т. 5. — № 7. — С. 59–68. [Stolbovoy AV, Islim N, Loiko IE, et al. Issues in the treatment of cervix uteri. Clinical analysis in general medicine. 2024;5(7):59–68. (In Russ.)] doi: https://doi.org/10.47407/kr2024.5.7.00448</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Aronowitz JN, Aronowitz SV, Robison RF. Classics in brachytherapy: Margaret Cleaves introduces gynecologic brachytherapy. Brachytherapy. 2007;6(4):293–297. doi: https://doi.org/10.1016/j.brachy.2007.08.009</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Салим (Ислим) Н., Столбовой А.В., Рыжкин С.А. Критические особенности радиотерапии больных раком шейки матки // Клинический разбор в общей медицине. — 2025. — Т. 6. — № 9. — С. 89–94. [Islim (Salim) N, Stolbovoy AV, Ryzhkin SA. Critical issues in the radiotherapy of cervix utery cancer. Clinical review for general practice. 2025;6(9):89–94. (In Russ.)] doi: https://doi.org/10.47407/kr2025.6.9.00678</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Salim N, Tumanova K, Stolbovoy A, et al. Adaptive VMAT Radiotherapy to Avoid Brachytherapy in Cervical Cancer Treatment. International Journal of Radiation Oncology, Biology, Physics. 2022;114(3 suppl). № 2583. e262.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Салим (Ислим) Н., Лойко И.Е., Зверева Д.П., и др. Два клинических случая радикальной дистанционной радиотерапии рака шейки матки при невозможности использовать брахитерапию // Клинический разбор в общей медицине. — 2025. — Т. 6. — № 12. — C. 22–30. [Islim (Salim) N, Loyko IE, Zvereva DP, et al. Two cases of forced external beam radiotherapy of the cancer of cervix uteri when brachytherapy is impossible. Clinical review for general practice. 2025;6(12):22–30. (In Russ.)] doi: https://doi.org/10.47407/kr2025.6.12.00p4548</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Титова В.А. Рак шейки матки: реалистичный подход к эволюционному развитию лучевой терапии, интеллектуальные и технические возможности. Взгляд эксперта // Вестник Российского научного центра рентгенорадиологии. — 2022. — Т. 22. — № 4. — С. 361–372. [Titova VA. Rak shejki matki: realistichnyj podhod k evolyucionnomu razvitiyu luchevoj terapii, intellektual’nye i tekhnicheskie vozmozhnosti. Vzglyad eksperta. Vestnik Rossijskogo nauchnogo centra rentgenoradiologii. 2022;22(4);361–372. (In Russ.)]</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Солодкий В.А., Титова В.А., Паньшин Г.А. Эволюционное развитие технологий лучевой терапии местнораспространенного рака шейки матки // Вопросы онкологии. — 2023. — Т. 69. — № 1. — С. 15–23. [Solodkiy VA, Titova VA, Panshin GA. Evolutionary development of radiotherapy technologies in locally advanced cervical cancer. Voprosy Onkologii. 2023;69(1):15–23. (In Russ.)] doi: https://doi.org/10.37469/0507-3758-2023-69-1-15-23</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Солодкий В.А., Титова В.А., Паньшин Г.А. Современная конформная лучевая терапия при противоопухолевом лечении местнораспространенного рака шейки матки // Вопросы онкологии. — 2023. — Т. 69. — № 5. — С. 824–834. [Solodky VA, Titova VA, Panshin GA. Modern Conformal Radiation Therapy in the Antitumor Treatment of Locally Advanced Cervical Cancer. Voprosy Onkologii. 2023;69(5):824–834. (In Russ.)] doi: https://doi.org/10.37469/0507-3758-2023-69-5-824-834</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Паньшин Г.А., Титова В.А. Возможно ли и нужно ли не применять брахитерапию при радиотерапевтическом лечении больных местнораспространенным раком шейки матки? // Вопросы онкологии. — 2024. — Т. 70. — № 3. — С. 557–563. [Panshin GA, Titova VA. Is it Possible and Necessary to Avoid Using Brachytherapy when Giving Radiation Therapy for Locally Advanced Cervical Cancer? Voprosy Onkologii. 2024;70(3):557–563. (In Russ.)] doi: https://doi.org/10.37469/0507-3758-2024-70-3-557-563</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Семьдесят третья сессия Всемирной ассамблеи здравоохранения WHA73.2 Пункт 11.4 повестки дня 3 августа 2020 г. Глобальная стратегия по ускорению элиминации рака шейки матки как проблемы общественного здравоохранения и установленные в ней цели и задачи на период 2020–2030 гг. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_R2-ru.pdf (accessed: 09.02.2022).</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Семьдесят восьмая сессия Всемирной ассамблеи здравоохранения. WHA78. Всемирная организация Здравоохранения. Документ EB156(22). Всемирный день элиминации рака шейки матки. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://apps.who.int/gb/ebwha/pdf_files/EB156/B156_(22)-ru.pdf (accessed: 05.06.2025).</mixed-citation></ref></ref-list></back></article>
